The research, presented at the American Society of Hematology 2018 Annual Meeting, found a simple and standardized management strategy to yield low rates of bleeding and thromboembolism.
In other news—new data suggest doing away with one-size-fits-all approaches for PCI in patients with current or historical cancers and clinical management of high-risk heart failure patients. In these cases, precision medicine can have a massive positive impact on quality care.
|
